Friday, July 23, 2010

Money and Medicine: The Story of Avandia

Nice piece on the controversy surrounding Avandia, or rosiglitazone. I think it should be pulled from the market or that additional black box warnings accompany the medication.  Risk-benefit ratio just doesn't add up to me.

...of course, people should make their decisions in consultation with their physician, not my online musings...

This is a nice timeline of significant events with Avandia. Below is the video interview:

Watch the full episode. See more Need To Know.

No comments: